Small Molecule
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
87
NCT05109091
Study of ATH434 in Participants with Multiple System Atrophy
Phase: Phase 2
Role: Lead Sponsor
Start: Jul 1, 2022
Completion: Nov 28, 2024
NCT05864365
A Biomarker Study of ATH434 in Participants With MSA
Start: May 23, 2023
Completion: Feb 26, 2025
Loading map...